Clinical Trial

A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Name: A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD) — clinical trial record (NCT07292714)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The study is a Phase II, multicenter, double-blind, randomized, parallel, placebo-controlled clinical trial designed to evaluate the efficacy, safety of 9MW1911 in patients with Chronic Obstructive Pulmonary Disease (COPD).

Trial Details

NCT Number	NCT07292714
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	Chronic Obstructive Pulmonary Disease COPD
Enrollment	360 participants
Start Date	2025-07-15
Primary Completion	2027-12 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2025-12-18